USPTO serial 97524379
INSPIRED CARE
Reviewed by CopyMark Law Group
Status 734Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SINGH, DEEP K
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with INSPIRED CARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven J. Nataupsky
Steven J. Nataupsky KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical catheters for use in the peripheral, coronary, and neurovasculature; Component parts of medical catheters; Medical catheters for use in the brain of a patient; Digital health devices in the nature of digital monitoring devices, for use in telemedicine, and for use in behavioral health and community health, for monitoring biomarkers of patients; Medical devices for the detection, diagnosis, and treatment of strokes; physical and neuro rehabilitation devices for use with stroke patients; Medical devices, namely, access catheters for the introduction of interventional medical devices into the peripheral, coronary, and neuro vasculature; Access sheaths, namely, surgical apparatus and instruments for use in the brain of a patient; Medical sheaths, namely, surgical apparatus and instruments and catheters for use in neurovascular, cardiovascular and peripheral vascular procedures; Aspiration catheters for use in the vascular system; Medical devices, namely, catheters for vascular use; Medical apparatus and instruments for use in neurovascular, cardiovascular, and peripheral vascular procedures; Diagnostic apparatus for medical purposes; Medical body rehabilitation apparatus; Medical devices, namely, catheters, stents, guidewires, implantable drug coated stent, wearable monitors for monitoring vital signs, stroke rehabilitation devices in the nature of physical, cognitive, and speech-language-pathology rehabilitation devices; Medical devices in the nature of balloon catheters; Medical devices, namely, wearable and remote portable medical devices with firmware, connectivity and algorithms, for monitoring physiologic signals and/or detecting changes in health related to onset of or recovery from neurological injury, as well as general health; Stroke rehabilitation devices in the nature of physical, cognitive, and speech-language-pathology rehabilitation devices; Wellness devices, namely, wearable and remote portable medical devices with firmware and connectivity, for monitoring physiologic signals; Robotic devices for use in connection with transvascular medical procedures; Robotic drive systems, namely, catheters for use in transvascular medical procedures; Robotic guidewire drive systems for use in transvascular medical procedures; Medical devices for automated movement in the nature of, a robotic system comprising motors having rotational and/or translational movement capability for use in robotic control of catheters and/or guidewires; Robotic guided catheters for use in transvascular medical procedures; Robotic guided guidewires for use in transvascular medical procedures; Computerized surgical control systems, namely, robotic guidewire devices for use in transvascular medical procedures; Medical catheters for use in the neurovascular system; Medical devices for the treatment of strokes; Aspiration catheters for use in the neurovascular system; Medical devices, namely, vacuum pumps for use in the neurovascular system; Medical filters for use in the neurovascular system; Medical devices, namely, medical tubing, medical aspiration tubing and medical filters for capturing debris and clots in the bloodstream; Medical devices, namely, catheters, access catheters for use in the vascular system, aspiration catheters for use in the vascular system, medical vacuum pumps, medical tubing, and parts and fittings for the aforementioned goods; Medical, surgical and healthcare apparatus and instruments in the nature of thrombus removal devices, clot removal devices, emboli removal devices, catheters, catheters for treating deep vein thrombosis, catheters for treating pulmonary embolisms, catheters for treating peripheral arterial occlusions, dialysis catheters, aspiration control handles, vacuum pumps, tubing sets, filters and parts and fittings for the aforementioned goods; buttons or switches, namely, medical, surgical or healthcare apparatus and instrument for thrombus removal, clot removal, or emboli removal; Aspiration control handles and buttons or switches integral to catheters, namely, catheter for treating pulmonary embolisms, catheter for treating deep vein thrombosis, vacuum pump, tubing set, or filter for medical purposes; Catheters for dialysis; Aspiration control handles, namely, medical apparatus and instruments for use in neurovascular, cardiovascular, and peripheral vascular procedures; Vacuum pumps for medical purposes; Blood tubing sets for medical purposes; Filters for medical purposes, namely, medical filters for capturing debris and clots in the bloodstream, and parts and fittings for the aforementioned goods; A component of medical catheters or sheaths, namely, medical apparatus and instruments for use in dialysis and treating deep vein thrombosis, coronary occlusions, and peripheral artery occlusions; Catheters for treating pulmonary embolisms and deep vein thrombosis; Catheters for treating peripheral arterial occlusions; Catheters for treating coronary occlusions; Blood tubing sets for medical purposes for removal of blood and thrombus, aspiration, and removing occlusions, and filters and parts and fittings for the aforementioned goods; Component of medical, surgical, or healthcare apparatus, namely, a container for medical waste for the capture and removal of thrombus removal, clot removal, or emboli removal; Component of medical, surgical, or healthcare apparatus, namely, canisters for the capture and removal of thrombus, clots or emboli | ACTIVE | — |
| 012 | Surgical carts for use in transvascular medical procedures | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 26, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 25, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 24, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 16, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 15, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 24, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 23, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 23, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 23, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 2, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 1, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 1, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 1, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 22, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 22, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 22, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 24, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 23, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 23, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 23, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 23, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 24, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 24, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 24, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 19, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 19, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 19, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 19, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 6, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Sep 6, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 7, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2022 | NWAP | NEW APPLICATION ENTERED | — |